Seres Therapeutics Inc Forecast, price target & analysts
$11.87
9.30%
Nasdaq,
Jul 03, 10:52 pm CET
Seres Therapeutics Inc Target price 2025 - Analyst rating & recommendation
Powered by
Seres Therapeutics Inc Classifications & Recommendation:
Buy
64%
Hold
27%
Sell
9%
Seres Therapeutics Inc Price Target
| Target Price | $14.28 |
| Price | $11.87 |
| Potential |
20.30%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Seres Therapeutics Inc 2026 .
The average Seres Therapeutics Inc target price is $14.28.
This is
20.30%
register free of charge
$128.52
982.73%
register free of charge
$6.06
48.95%
register free of charge
|
|
| A rating was issued by 11 analysts: 7 Analysts recommend Seres Therapeutics Inc to buy, 3 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Seres Therapeutics Inc stock has an average upside potential 2026 of
20.30%
register free of charge
|
Current Seres Therapeutics Inc Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Chardan Capital |
Locked
➜
Locked
|
Locked | May 08 2025 |
| Chardan Capital |
Locked
➜
Locked
|
Locked | Mar 20 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Mar 14 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Nov 14 2024 |
| Chardan Capital |
Locked
➜
Locked
|
Locked | Nov 13 2024 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Oct 24 2024 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Sep 13 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Chardan Capital:
Locked
➜
Locked
|
May 08 2025 |
|
Locked
Chardan Capital:
Locked
➜
Locked
|
Mar 20 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Mar 14 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Nov 14 2024 |
|
Locked
Chardan Capital:
Locked
➜
Locked
|
Nov 13 2024 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Oct 24 2024 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Sep 13 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
